학술논문

Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10.
Document Type
journal article
Source
Journal of Clinical Oncology; 10/10/2019, Vol. 37 Issue 29, p2601-2609, 11p
Subject
Language
ISSN
0732183X